---
$id: https://graph.org.ai/products/commodity/51321902
$type: Product
source: UNSPSC
code: "51321902"
title: "Eflucimibe"
class: "51321900"
classTitle: "Antihyperlipidemic and hypocholesterolemic amides"
family: "51320000"
familyTitle: "Antihyperlipidemic and hypocholesterolemic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Eflucimibe

**UNSPSC Code**: 51321902
**Class**: [Antihyperlipidemic and hypocholesterolemic amides](Antihyperlipidemic and hypocholesterolemic amides.mdx)
**Family**: [Antihyperlipidemic and hypocholesterolemic agents](../Antihyperlipidemic and hypocholesterolemic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-lipidemic agent with the molecular formula C29H43NO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3DK1X2C37M, chemically known as (s)-2,3,5-trimethyl-4-hydroxy-alpha-dodecylthioacetanilide but generally known as eflucimibe, which bears US NIH Compound Identifier 3025954. The term EFLUCIMIBE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 3-4, 2001, List 46). Most nations schedule eflucimibe under HS 29309085 and SITC 51549. As of Q4 2014, EFLUCIMIBE remains the US FDA Preferred Term for this commodity. Eflucimibe bears US NLM identifiers UMLS ID C0963171 and NCI Concept Code C75995. SMILES: CCCCCCCCCCCCCC(=S)NC1=C(C(=C(C(=C1)C)O)C)C.

